Delafloxacin an Effective Option for Acute Bacterial Skin Infections Delafloxacin an Effective Option for Acute Bacterial Skin Infections

Delafloxacin is non-inferior to vancomycin plus aztreonam for treating acute bacterial skin and skin-structure infections (ABSSSI), according to a new phase 3 trial.Reuters Health Information
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Infectious Diseases News Source Type: news